Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 21, 2025
Switching From Standard to Extended Half-Life Coagulation Factor Replacement in Haemophilia: Clinical Outcomes and Costs of Care in FinlandMirkka Koivusalo, Timea Szanto, Tuomas Kovalainen, et al.
Transfusion|November 27, 2020
Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA studyAnu Partanen, Antti Turunen, Jaakko Valtola, et al.
Leukemia & Lymphoma|August 31, 2018
Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter studyJaakko Valtola, Raija Silvennoinen, Antti Ropponen, et al.
Transfusion|May 29, 2015
Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparisonJaakko Valtola, Ville Varmavuo, Antti Ropponen, et al.
Journal of Clinical Apheresis|October 14, 2022
Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA studyAnu Partanen, Antti Turunen, Raija Silvennoinen, et al.
Transfusion|May 6, 2021
Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA studyAntti Turunen, Raija Silvennoinen, Anu Partanen, et al.
Leukemia & Lymphoma|May 19, 2020
Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA studyAntti Turunen, Jaakko Valtola, Anu Partanen, et al.
Basic & Clinical Pharmacology & Toxicology|April 28, 2025
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre TrialSari Kytölä, Mika Kurkela, Johanna I Kiiski, et al.
Hemasphere|January 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacyIda Vänttinen, Joseph Saad, Tanja Ruokoranta, et al.
Transfusion|April 26, 2020
CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA studyAntti Turunen, Anu Partanen, Jaakko Valtola, et al.
Pageof 4